EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Infectomics of Chikungunya Virus: Roles Played by Host Factors

Nur Amelia Azreen Binti Adnan, Nida Kalam, Gabriel Lim Zi Jiunn, Thamil Vaani Komarasamy, Vinod R M T Balasubramaniam

The American Journal of Tropical Medicine and Hygiene · 2025

DOI: 10.4269/ajtmh.23-0819 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von Nur Amelia Azreen Binti Adnan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia. Hauptthemen laut MEDLINE: Chikungunya virus, Chikungunya Fever, Host-Pathogen Interactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chikungunya virus (CHIKV), prevalent in tropical regions, is known for causing frequent outbreaks, particularly in Central Africa, South America, and Southeast Asia. It is an arbovirus transmitted by the Aedes ( Ae. ) aegypti and Ae. albopictus mosquitoes. Infections lead to severe joint and muscle pain, which can linger and significantly impair an individual’s health, quality of life, and economic stability. Recent climatic changes and the globalization of travel have facilitated the worldwide spread of these mosquitoes. Currently, no U.S. Food and Drug Administration (FDA) approved drug is available for treating CHIKV infection. Recently, the FDA approved a live, attenuated vaccine called Ixchiq. However, this vaccine has been linked to side effects, leading the FDA to mandate additional post-marketing studies to assess the risk of severe adverse reactions similar to the virus. An emerging strategy in drug development focuses on targeting host factors that the virus exploits rather than the viral proteins themselves. This review explores the interactions between CHIKV and host factors that could be potential therapeutic targets. Despite progress in understanding the life cycle of CHIKV, the immune system’s role in combating the virus still needs to be fully understood. Investigating treatments that enhance the host’s immune response may offer new paths to combating CHIKV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chikungunya virusChikungunya FeverHost-Pathogen InteractionsHumansAnimalsAedesMosquito VectorsAntiviral Agents

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.

Zitieren

APA

Binti Adnan, N. A. A., Kalam, N., Lim Zi Jiunn, G., Komarasamy, T. V., & Balasubramaniam, V. R. M. T. (2025). Infectomics of Chikungunya Virus: Roles Played by Host Factors. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0819

Vancouver

Binti Adnan NAA, Kalam N, Lim Zi Jiunn G, Komarasamy TV, Balasubramaniam VRMT. Infectomics of Chikungunya Virus: Roles Played by Host Factors. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.23-0819

BibTeX
@article{BintiAdnan2025,
  author = {Binti Adnan, Nur Amelia Azreen and Kalam, Nida and Lim Zi Jiunn, Gabriel and Komarasamy, Thamil Vaani and Balasubramaniam, Vinod R M T},
  title = {Infectomics of Chikungunya Virus: Roles Played by Host Factors},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2025},
  doi = {10.4269/ajtmh.23-0819}
}
Kostenlos starten →